Profile
David S.
Arrington worked as VP-Investor Relations & Corporate Communications at Achaogen, Inc. from 2017 to 2018.
He also worked as VP-Investor Relations & Corporate Affairs at Coherus BioSciences, Inc. and as VP-Investor Relations & Corporate Communications at Freeline Therapeutics Holdings Plc.
Arrington received his undergraduate degree from Washington State University.
Former positions of David S. Arrington
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | Investor Relations Contact | 2018-03-31 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Investor Relations Contact | - |
| COHERUS BIOSCIENCES, INC. | Investor Relations Contact | - |
Training of David S. Arrington
| Washington State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- David S. Arrington
